Soluble epoxide hydrolase inhibition enhances anti-inflammatory and antioxidative processes, modulates microglia polarization, and promotes recovery after ischemic stroke
Chien-Fu Yeh,1–3,* Tung‐Yueh Chuang,4,* Yu-Wen Hung,5 Ming-Ying Lan,2,3 Ching-Han Tsai,4 Hao-Xiang Huang,4 Yung-Yang Lin1,4,6–8 1Institute of Brain Science, National Yang-Ming University, Taipei 11221, Taiwan; 2Department of Otorhinolaryngology, National Yang-Ming University, Tai...
Main Authors: | Yeh CF, Chuang TY, Hung YW, Lan MY, Tsai CH, Huang HX, Lin YY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/soluble-epoxide-hydrolase-inhibition-enhances-anti-inflammatory-and-an-peer-reviewed-article-NDT |
Similar Items
-
Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury
by: K. Lockhart Jamieson, et al.
Published: (2021-02-01) -
Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
by: Chun-Hu Wu, et al.
Published: (2017-11-01) -
Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction
by: Yajun Gui, et al.
Published: (2018-05-01) -
Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
by: Hsueh-Te Lee, et al.
Published: (2019-12-01) -
Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders
by: Qian Ren, et al.
Published: (2019-04-01)